[PDF] Top 20 Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study
Has 10000 "Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study" found on our website. Below are the top 20 most common "Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study".
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study
... major osteoporosis-related and hip fractures were individually analyzed in the TROPOS ...(method of Genant et al.; Ref. 11). Vertebral x-rays were not mandatory in TROPOS ... Voir le document complet
7
Strontium ranelate reduces the risk of vertebral fractures in osteoporotic postmenopausal women whatever the baseline vertebral fractures status
... Background: The anti-fracture efficacy of strontium ranelate 2g/day, a new orally active anti-osteoporotic agent with an innovative mode of action both increasing bone formation ... Voir le document complet
1
Strontium ranelate decreases the risk of hip fracture over 3 and 5 years in post menopausal women at high risk
... Objectives: Strontium ranelate is an effective anti-osteoporotic treatment with a unique mode of action increasing bone formation while decreasing bone ...efficacy of ... Voir le document complet
1
Effects of Strontium Ranelate on Spinal Osteoarthritis Progression
... and TReatment Of Peripheral OSteoporosis (TROPOS) trials performed on 1105 women with osteoporosis and concomitant radiological spinal OA at baseline, and for whom lumbar ... Voir le document complet
6
Ultrasound-based estimates of cortical bone thickness and porosity are associated with non-traumatic fractures in postmenopausal women: A pilot study
... Our study had several limitations. A first limitation is the overall small number of patients and particularly the small number of fractures in each ...pilot study ... Voir le document complet
54
Positive effects of strontium ranelate on spine osteoarthritis progression
... patients with spinal OA, with (n=682) or without (n=423) prevalent vertebral fracture, and with lumbar X-rays available at baseline and after 3 years were included in this post-hoc analysis ... Voir le document complet
1
Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate
... greater risk of sustaining a vertebral fracture than patients whose BMD ...increases in BMD tended to observe greater reductions in vertebral fracture risk ...regression, the ... Voir le document complet
6
Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs.
... Abstract The incidence of osteoporosis and cardiovascular disease increases with age, and there are potentially shared mechanis- tic associations between the two ...understand ... Voir le document complet
16
Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women
... Our study considered real-world adher- ence with oral bisphosphonate therapy while determining the cost-effectiveness of ...and osteoporosis and fracture care costs were obtained from ... Voir le document complet
12
Potential of pomegranate and its derivatives for the prevention of bone loss in a preclinical mice model of postmenopausal osteoporosis
... benefits of pomegranate (PG) have raised a growing scientific ...endowed with anti-inflammatory and antioxidant activities, we hypothesized that it may have beneficial effects on ... Voir le document complet
2
Le ranelate de strontium (Protelos)
... Le ranelate de strontium possède un méca- nisme d’action original, associant une inhibition de la résorption ostéoclastique et une stimula- tion concomitante de la formation ...du ranelate de ...le ... Voir le document complet
3
Review of the guideline of the American College of Physicians on the treatment of osteoporosis.
... Gains in BMD following treatment with teriparatide and abaloparatide are very substantial compared with the bisphosphonates, SERMs, and denosumab and are expected to be translated ... Voir le document complet
6
Pomegranate seed oil for nutritional management of postmenopausal osteoporosis: in vitro and preclinical studies
... management of postmenopausal osteoporosis: in vitro and preclinical studies Mélanie Spilmont 1,2,3,6 , Laurent Léotoing 1,2,3 , Marie-Jeanne Davicco 1,2,3 , Patrice Lebecque 1,2,3 , Sylvie ... Voir le document complet
2
Reduction in vertebral fracture rates by a combination of monofluorophosphate and raloxifene in postmenopausal osteoporosis
... Faculty of Medecine, Prague, Czech republic, 4 First Clinic of Internal Medicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia, 5 Internal Medicine, St Vincent Hospital, Vienna, ... Voir le document complet
1
Hormone therapy and risk of venous thromboembolism among postmenopausal women
... safety of transdermal estrogens with respect to thrombotic ...influencing the risk associated with hormone therapy, different estrogen and progestogen formulations, different modes ... Voir le document complet
10
A study of intravascular brachytherapy treatment planning in peripheral arteries.
... RESULTS In order to evaluate our methodology, we considered four data sets acquired from helical CT scanner, one from a phantom model, one from pre-PTA iliac artery and two from post-PTA sheep iliac ...kinds ... Voir le document complet
4
Osteoporosis prevention: Where are the barriers to improvement in French general practitioners? A qualitative study
... by the GPs for the initiation of OP treatment: over-medication in elderly patients, non-adherence due to a lack of concern, and suspicion about treatment side effects; ... Voir le document complet
13
[Menopause hormonal treatment and risk of breast cancer: comments on the results of the Million Women Study]
... Figure 2. Risque relatif de cancer du sein invasif en fonction de la molécule, de la dose et de la voie d'administration de l'estrogène seul utilisé à l'inclusion. D'après la Million Women Study [2]. ... Voir le document complet
4
Cross-cultural validation and analysis of responsiveness of the QUALIOST: QUAlity of Life questionnaire In OSTeoporosis.
... entity, strontium ranelate, was implemented in post- menopausal women with ...osteoporosis. The SOTI (Spinal Osteoporosis Therapeutic Intervention) study was ... Voir le document complet
11
A prospective study of the association between endogenous hormones and depressive symptoms in postmenopausal women.
... limitation of the present study is the relatively small sample size such that it is possible the negative findings result from a lack of power to detect statistical ... Voir le document complet
12
Sujets connexes